- Home
- AKRO vs APAM Comparison
AKRO vs APAM Comparison
Compare AKRO & APAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- APAM
- Stock Information
- Founded
- AKRO 2017
- APAM 1994
- Country
- AKRO United States
- APAM United States
- Employees
- AKRO N/A
- APAM N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- APAM Investment Managers
- Sector
- AKRO Health Care
- APAM Finance
- Exchange
- AKRO Nasdaq
- APAM Nasdaq
- Market Cap
- AKRO 3.9B
- APAM 3.3B
- IPO Year
- AKRO 2019
- APAM 2013
- Fundamental
- Price
- AKRO $50.09
- APAM $47.78
- Analyst Decision
- AKRO Strong Buy
- APAM Hold
- Analyst Count
- AKRO 7
- APAM 6
- Target Price
- AKRO $81.57
- APAM $43.42
- AVG Volume (30 Days)
- AKRO 997.3K
- APAM 591.5K
- Earning Date
- AKRO 08-08-2025
- APAM 07-29-2025
- Dividend Yield
- AKRO N/A
- APAM 7.47%
- EPS Growth
- AKRO N/A
- APAM 12.91
- EPS
- AKRO N/A
- APAM 3.78
- Revenue
- AKRO N/A
- APAM $1,136,529,000.00
- Revenue This Year
- AKRO N/A
- APAM $6.76
- Revenue Next Year
- AKRO N/A
- APAM $8.17
- P/E Ratio
- AKRO N/A
- APAM $12.65
- Revenue Growth
- AKRO N/A
- APAM 10.03
- 52 Week Low
- AKRO $21.34
- APAM $32.75
- 52 Week High
- AKRO $58.40
- APAM $49.54
- Technical
- Relative Strength Index (RSI)
- AKRO 49.73
- APAM 59.36
- Support Level
- AKRO $47.10
- APAM $45.07
- Resistance Level
- AKRO $53.02
- APAM $48.46
- Average True Range (ATR)
- AKRO 2.14
- APAM 1.15
- MACD
- AKRO -0.01
- APAM 0.13
- Stochastic Oscillator
- AKRO 51.97
- APAM 86.04
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About APAM Artisan Partners Asset Management Inc.
Artisan Partners Asset Management Inc is a investment management firm providing a range of investment strategies to a diverse group of clients around the world. Each of the company's strategies is managed by one of its several investment teams. Investment management services are offered to institutions through separate accounts and mutual funds. Artisan's investment offerings include several long-only, equity investment strategies across a multitude of market capitalization segments and investing styles in both the United States and international markets. In addition to its equity strategies, customers may invest in a fixed-income strategy. Strategies are often distributed to customers ranging from retail investors to institutional investors through specialized channels.